India, Oct. 30 -- The shares of this small cap company majorly engaged in offering wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines, were in focus after announcing Q3 CY26 results

With the market capitalization of Rs. 7,542 Crores, the shares of Sanofi India Ltd reached an intraday high of Rs. 3,422.60 per share rising nearly 7 percent from its previous day close of Rs. 3,189.50 per share and is trading at a P/E of 20.7 whereas industry P/E stands at 34.6.

Q3 CY26 Results & Dividend announcement YoY Performance: Sanofi India's revenue increased 4 percent to Rs. 492 crore from Rs. 475 crore. Operating profit rose 20 percent to Rs. 161 crore from Rs. 134 crore...